BLADDER TRANSITIONAL CELL CARCINOMA STAGE 0

This adverse event was reported 26 times

These drugs are most commonly taken by patients reporting BLADDER TRANSITIONAL CELL CARCINOMA STAGE 0:

# Drug Count
0 LENALIDOMIDE 12
1 DEXAMETHASONE 8
2 DEXAMETHASONE 1.5 MG 8
3 PANTOPRAZOLE 7
4 PREDNISONE 7
5 PIOGLITAZONE 6
6 INSULIN GLARGINE 5
7 ROSUVASTATIN 5
8 ALLOPURINOL 4
9 CANDESARTAN CILEXETIL 4
See all common drugs associated with BLADDER TRANSITIONAL CELL CARCINOMA STAGE 0

BLADDER TRANSITIONAL CELL CARCINOMA STAGE 0 is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE 2 0.0007
1 ELOTUZUMAB 2 0.0004
2 HYDROXYZINE PAMOATE 1 0.0003
3 REPAGLINIDE 2 0.0003
4 CANDESARTAN CILEXETIL 4 0.0002
5 HUMAN IMMUNOGLOBULIN G 3 0.0001
6 PIOGLITAZONE 6 0.0001
7 ENFORTUMAB VEDOTIN 1 0.0001
8 FONDAPARINUX SODIUM 1 0.0001
9 MELPHALAN HYDROCHLORIDE 3 0.0001
See all drugs enriched for association with BLADDER TRANSITIONAL CELL CARCINOMA STAGE 0